In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health ...
Hologic took on considerable leverage after its $3.8 billion acquisition of Gen-Probe in 2012, but deleveraged in the ensuing years and avoided piling on more debt for the purchase of Cynosure. As of ...